Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway
US7452530B2 · kind B2 · utility
5Cited by
17References
28Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 21, 2004 |
| Grant date | Nov 18, 2008 |
| Priority date | — |
| Expiry date | Oct 13, 2024 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides methods of inducing an antiviral response in an individual comprising administering to the individual an effective amount of a LT-B blocking agent and a pharmaceutically acceptable carrier. In particular this invention provides methods for treating viral-induced systemic shock and respiratory distress.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.